Rappel de Device Recall ADVIA Chemistry XPT

Selon U.S. Food and Drug Administration, ce/cet/cette rappel concerne un dispositif en/au/aux/à United States qui a été fabriqué par Siemens Healthcare Diagnostics, Inc..

Qu'est-ce que c'est?

Une correction ou un retrait opéré par un fabricant afin de répondre à un problème causé par un dispositif médical. Les rappels surviennent lorsqu'un dispositif médical est défectueux, lorsqu'il pourrait poser un risque pour la santé, ou les deux à la fois.

En savoir plus sur les données ici
  • Type d'événement
  • ID de l'événement
  • Classe de risque de l'événement
    Class 2
  • Numéro de l'événement
  • Date de mise en oeuvre de l'événement
  • Statut de l'événement
  • Pays de l'événement
  • Source de l'événement
  • URL de la source de l'événement
  • Notes / Alertes
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notes supplémentaires dans les données
    Assay, glycosylated hemoglobin - Product Code LCP
  • Cause
    Siemens identified an issue with the ratio equation provided on the advia chemistry xpt system software test definition (tdef) version 1.0 disks (smn: 11127343 and 11222123). this issue affects only the advia chemistry hemoglobin a1c_3 automated pretreatment (a1c_3) results when hba1c values are reported in international federation of clinical chemistry (ifcc) equivalent units (hba1cr). the ratio equation used to calculate advia chemistry hemoglobin a1c_3 automated pretreatment (a1c_3) results in ifcc units contains an error. the error results in falsely depressed hba1cr results.
  • Action
    Siemens sent an Urgent Field Safety Notice dated July 20, 2016, to all affected customers via Fed Ex and the Urgent Field Safety Notice (CHSW16-02 July 2016) was e-mailed to regional countries for implementation Outside US (OUS). Customers have been advised to stop reporting results and call Siemens immediately to schedule service. The file with the typographical error is located on ADVIA Chemistry XPT Test Definition (TDef) disk. -- Field service personnel were sent a support bulletin describing the issue and instructing them how to correct the equation. Service engineers have been instructed to remove all version 1.0 TDef disks from customer sites regardless of whether they run the ADVIA Chemistry Hemoglobin A1c_3 Automated Pretreatment assay and report in IFCC units. Customers with questions were advised to contact their Siemens Customer Care Center or their local Siemens technical support representative.


  • Modèle / numéro de série
    CA1275002940294 and lower
  • Classification du dispositif
  • Classe de dispositif
  • Dispositif implanté ?
  • Distribution
    Worldwide Distribution - US to MA, NY, MI, IL, TX, CO, AZ, CA, WA and Foreign distribution to the following countries: Australia, Austria, Bahrain, Brazil, China, Denmark, Egypt, Finland, France, Germany, Greece, Hungary, Italy, Malaysia, Netherlands, New Zealand, Norway, Portugal, Portugal, Republic Korea, Singapore, Slovakia, Spain, Sweden, Turkey, United Kingdom, and Vietnam.
  • Description du dispositif
    ADVIA Chemistry XPT, SMN 10723034, IVD. --- This issue affects only the ADVIA Chemistry Hemoglobin A1c_3 Automated Pretreatment (A1c_3) results when HbA1c values are reported in International Federation of Clinical Chemistry (IFCC) equivalent units (HbA1cR). || The ADVIA Chemistry XPT System is an automated, clinical chemistry analyzer that runs tests on serum, plasma, urine, or cerebral spinal fluid in random access and batch modes at a throughput rate of both 1800 photometric tests per hour and 600 electrolyte (ISE) tests per hour
  • Manufacturer


  • Adresse du fabricant
    Siemens Healthcare Diagnostics, Inc., 511 Benedict Ave, Tarrytown NY 10591-5005
  • Société-mère du fabricant (2017)
  • Source